219638-16-1Relevant articles and documents
Selective cytotoxicity of azatyrosinamides against ras-transformed NIH 3T3 cells
Wang,Hwang,Lee, On,Tseng,Shu,Lee
, p. 4272 - 4274 (2005)
This study aims to develop novel azatyrosinamide compounds structurally modified from ras-specific antioncogenic azatyrosine. Analogues 4-15 were prepared and their inhibition on the growth of wild-type and ras-transformed NIH 3T3 cell lines was compared. Compound 12 was found to be the most active with IC50 16.5 ± 2.2 μM which is 458-fold more potent than that of azatyrosine. The selective toxicity, defined as IC 50 wild-type/IC50 ras-transformed for this compound was 138.5.